BioCancell Ltd. (BioCancell)

Oncology Corporate Profile

HQ Location

1/3 High-Tech Village
Givat Ram
Jerusalem, Israel 9139102

Company Description

BioCancell is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat cancer-related diseases. Its most advanced product candidate, BC-819, is under development as a treatment for non-muscle-invasive bladder cancer (NMIBC). BC-819 will enter two Phase III confirmatory studies in the first half of 2016.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
BC-819DNA PlasmidBladder cancerIII
BC-819 (+ BCG)DNA PlasmidBladder cancerII

View additional information on product candidates here »


Recent News Headlines

There are no news items to display